Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

David Filmore

Executive Editor

Rochester, NY
David Filmore has been covering the health care sector as a writer and editor for 16 years. He specializes in devices and diagnostics, particularly focusing on the regulatory and reimbursement dynamics that impact a company’s ability to succeed in the marketplace. Originally trained as a scientist, Dave enjoys dissecting technical topics to reach a core understanding. As a writer and editor, he relishes communicating that understanding, important context and key takeaways for practical use by the reader. Dave has led operations or served on the staff of “The Gray Sheet” for more than a decade, and now oversees Regulatory and Policy content for the new Medtech Insight. Previously, he was an editor with the American Chemical Society, producing content for professionals in the pharmaceutical industry and analytical instrumentation space. He has also worked in the pharma industry, and has a degree in chemistry. Dave lives with his wife and two kids in Rochester, NY.
Advertisement
Set Alert for Articles By David Filmore

Latest From David Filmore

Global Device Approvals, Weekly Snapshot: Pelvic Floor Strengthener, Peripheral Stent

A snapshot of medical device approvals captured in Medtech Insight's Approvals Tracker. A muscle stimulation device to treat urinary incontinence passed US FDA's review, while a peripheral artery stent with a new delivery system gained European sign off.

Approvals Gynecology & Urology

Device Week, Nov. 9, 2018 – What The US Midterms Mean For Medtech

On this week's podcast, David Filmore and Ferdous Al-Faruque discuss the results of this week's midterm elections in the US and what it could mean for the medtech sector.

Device Week Elections

3 Big Medtech Takeaways From US Midterms

The balance of power will be shifting in Washington, DC, following the Nov. 6 US midterm elections, but that probably will not mean major changes for medtech policies. Here are some key takeaways from the election for device and diagnostics companies.

Elections Legislation

US Regulatory Roundup, October 2018: It Wasn't All Scary

Troubling stories about US FDA inspections captured the attention of Medtech Insight readers last month. Other noteworthy US regulatory and policy themes from October: efforts to improve device reimbursement, salary trends, and a medtech focus in Congress.

Regulation Quality

Global Device Approvals, Weekly Snapshot: Parathyroid Detection, Diabetes Tech

A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. Two devices to help surgeons performing thyroid surgery made the list, as did several devices in the diabetes space.

Approvals Innovation

Device Companies Need To See Themselves As Digital Companies

As digital health rapidly expands its footprint, Cognizant's Vyom Bhuta says medical device companies need to evolve with the changing health-care landscape by making better use of the vast troves of available device data to improve products and patient lives.

Digital Health Market Access
See All
Advertisement
UsernamePublicRestriction

Register